Results 81 to 90 of about 25,068 (135)

[Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice bearing ectopic bladder cancer xenograft]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Chen S   +6 more
europepmc   +1 more source

肝癌患者合并多原发癌肝外肿瘤发病部位及诊断探讨

open access: yes, 2013
【目的】 尝试描述华南地区多原发癌合并肝癌患者的诊断时间间隔及好发部位,以帮助诊断策略的建立?【方法】 回顾性分析68例原发性肝癌伴肝外恶性肿瘤患者的诊断时间间隔?肝外恶性肿瘤发病部位?【结果】 18位患者肝癌先于肝外恶性肿瘤而诊断(H-O组),剩下50位患者肝外恶性肿瘤先于肝癌(O-H组)?平均确诊首发癌及继发癌的时间间隔为3年(0 ~ 18.7年)?时间间隔在O-H组与H-O组间无统计学差异(P < 0.50)?肝外恶性肿瘤包括鼻咽癌,结直肠癌,肺癌,皮肤癌,胃癌,食道癌,宫颈癌,乳腺癌,甲状腺癌 ...

core  

miR-143、miR-145在膀胱癌中的表达及意义

open access: yes, 2011
【目的】探讨膀胱癌中miR-143、miR-145的表达及其与膀胱癌临床病理特征的关系。【方法】采用miRNA表达谱芯片、Northen blot、Real-time PCR法检测miR-143、miR-145在膀胱癌中的表达,分析miR-143、miR-145的表达与膀胱癌临床分期分级的关系。【结果】miRNA表达谱芯片、Northen blot、Real-time PCR法均提示miR-143、miR-145在膀胱癌中较癌旁正常膀胱组织中表达明显降低,差异具有统计学意义。miR-143、miR ...

core  

[Analysis of self-control trial results of narrow band imaging and white light in transurethral resection of bladder tumor]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2020
Qiu M   +9 more
europepmc   +1 more source

[Advances in intravesical therapy for non<b>-</b>muscle<b>-</b>invasive bladder cancer]. [PDF]

open access: yesZhong Nan Da Xue Xue Bao Yi Xue Ban
Li J, Xue Y, Guo Z, Ye S, Ma Q, Jia X.
europepmc   +1 more source

[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2020
Zhao SM   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy